Publications of the KKNMS
Your search in the archive “Publications of the KKNMS” returned the following results:
-
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
Von Kowarik et al, erschienen in „J Neurol.“ (Vol. 261, Nr. 1, Januar 2014)
-
Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain
Von Paul F und Wattjes MP, erschienen in „Lancet“ (Vol. 383, Nr. 9912, Januar 2014)
-
Onset of secondary progressive phase and long-term evolution of multiple sclerosis
Von Scalfari et al, erschienen in „J Neurol Neurosurg Psychiatry“ (Vol. 85, Nr. 1, Januar 2014)
-
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Von International Multiple Sclerosis Genetics Consortium, erschienen in „Nat Genet.“ (Vol. 45, Nr. 11, November 2013)
-
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
Von Teunissen et al, erschienen in „Mult Scler.“ (Vol. 19, Nr. 13, November 2013)
-
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis
Von Warnke et al, erschienen in „Neurology“ (Vol. 81, Nr. 16, Oktober 2013)
-
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
Von Selter et al, erschienen in „Multiple Sclerosis Journal“ (Vol. 19, Nr. 11, Oktober 2013)
-
Hunting for autoantibodies in multiple sclerosis
Von Hemmer B und Srivastava R, erschienen in „Neurology“ (Vol. 81, Nr. 11, September 2013)
-
L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
Von Schwab et al, erschienen in „Neurology“ (Vol. 81, Nr. 10, September 2013)
-
An assay to quantify species-specific anti-JC virus antibody levels in MS patients
Von Warnke et al, erschienen in „Mult Scler J“ (Vol. 19, Nr. 9, August 2013)